These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25891945)
21. Thermal expansion of organic crystals and precision of calculated crystal density: a survey of Cambridge Crystal Database. Sun CC J Pharm Sci; 2007 May; 96(5):1043-52. PubMed ID: 17455328 [TBL] [Abstract][Full Text] [Related]
22. [Advances in the quantitative analytical methods of drug polymorphism]. Ma LW; Du W; Zhao CS Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512 [TBL] [Abstract][Full Text] [Related]
23. Informatics and modeling challenges in fragment-based drug discovery. Hubbard RE; Chen I; Davis B Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855 [TBL] [Abstract][Full Text] [Related]
24. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Almarsson O; Zaworotko MJ Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589 [TBL] [Abstract][Full Text] [Related]
25. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method. Kushida I; Gotoda M Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663 [TBL] [Abstract][Full Text] [Related]
33. Basic overview of chemoinformatics. Engel T J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169 [TBL] [Abstract][Full Text] [Related]
34. Intramolecular hydrogen bonding in medicinal chemistry. Kuhn B; Mohr P; Stahl M J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530 [TBL] [Abstract][Full Text] [Related]
35. "Predicting" Polymorphs of Pharmaceuticals Using Hydrogen Bond Propensities: Probenecid and Its Two Single-Crystal-to-Single-Crystal Phase Transitions. Nauha E; Bernstein J J Pharm Sci; 2015 Jun; 104(6):2056-2061. PubMed ID: 25904460 [TBL] [Abstract][Full Text] [Related]
36. Characterization of two polymorphs of lornoxicam. Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687 [TBL] [Abstract][Full Text] [Related]
37. Understanding the solid-state forms of fenofibrate--a spectroscopic and computational study. Heinz A; Gordon KC; McGoverin CM; Rades T; Strachan CJ Eur J Pharm Biopharm; 2009 Jan; 71(1):100-8. PubMed ID: 18590814 [TBL] [Abstract][Full Text] [Related]
38. QTAIM application in drug development: prediction of relative stability of drug polymorphs from experimental crystal structures. Abramov YA J Phys Chem A; 2011 Nov; 115(45):12809-17. PubMed ID: 21939257 [TBL] [Abstract][Full Text] [Related]
39. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. Heinz A; Strachan CJ; Gordon KC; Rades T J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341 [TBL] [Abstract][Full Text] [Related]
40. Polymorphic phase transitions: Macroscopic theory and molecular simulation. Anwar J; Zahn D Adv Drug Deliv Rev; 2017 Aug; 117():47-70. PubMed ID: 28939378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]